Answers are grounded in this paper and cite their sources.
The American Association for Cancer Research (AACR) Annual Meeting is a globally recognized event that focuses on the latest advances in basic, translational, clinical, and epidemiological cancer research. Over the years, the meeting has progressively shifted to a clinical focus, particularly in the liquid biopsy (LB) field, as demonstrated by the opening day plenary session dedicated to molecular residual disease (MRD). This editorial, prepared on behalf of the International Society of Liquid Biopsy (ISLB) Young Committee, highlights recent research efforts presented at the AACR Annual Meeting 2026, with a focus on LB methodologies and applications.
No takes yet. Share an insight, caveat, or question.
Pisapia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: